BioDelivery Sciences Provides an Update of Anticipated 2014 Milestones

BioDelivery Sciences Provides an Update of Anticipated 2014 Milestones
In addition, based on recruitment rates in a second Phase 3 clinical study of BEMA Buprenorphine in an opioid experienced patient group, the database for this trial is anticipated to be locked by mid-2014, with results following shortly thereafter …
Read more on SYS-CON Media (press release)

Day 2 Part 2-Shaianne’s Norco Detox Video Blog — In 6-7 hours I will have 48 hours clean. The worst is happening and will happen for a while. I am struggling to make videos to help another, please watch. Th…